🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety of a daily single oral ...
Status
Completed
Location
Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna
Start Date
2009-11
Trial ID
NCT01632605
Treatments Being Tested
The main objective of our study is to determine if treatment with sirolimus...
Status
Completed
Location
Loyola University Medical Center
Start Date
2020-04-24
Trial ID
NCT04341675
The purpose of this study is to determine the safety and feasibility of the...
Status
Completed
Location
University of Rochester
Start Date
2010-01
Trial ID
NCT00861874
Treatments Being Tested
Cancer drugs which target the effects of abnormal gene changes are called '...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2018-03-23
Trial ID
NCT03297606
RATIONALE: Drugs used in chemotherapy, such as sirolimus, work in different...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-08
Trial ID
NCT00311623
Treatments Being Tested
Background: The drug pemetrexed is used to treat non-small cell lung cance...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2008-02-29
Trial ID
NCT00923273
Treatments Being Tested
The purpose of this research is to study alternative treatments for the ski...
Status
Terminated
Location
University of California, Irvine
Start Date
2011-02
Trial ID
NCT01313923
Treatments Being Tested
Primary : To evaluate the efficacy of sirolimus assessed by the incidence o...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00478608
Treatments Being Tested
This is a pediatric kidney transplant study comparing the safety and effica...
Status
Recruiting
Location
University of Alabama at Birmingham (Site # 71038)
Start Date
2024-05-22
Trial ID
NCT06055608
This is a small phase I study with dose escalation and dose expansion cohor...
Status
Unknown
Location
Clinical Research Center
Start Date
2018-02-22
Trial ID
NCT03217669
Treatments Being Tested